Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Brinkmann

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1992
Alteration of a protease-sensitive region of Pseudomonas exotoxin prolongs its survival in the circulation of miceU Brinkmann, L H Pai, D J FitzGerald, et al.
Anticancer Research|November 29, 2001
Implication of the proliferation and apoptosis associated CSE1L/CAS gene for breast cancer developmentP Behrens, U Brinkmann, F Fogt, et al.
Clinical Chemistry and Laboratory Medicine|November 30, 2000
How to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transportC Meisel, I Roots, I Cascorbi, et al.
The American Journal of Dermatopathology|April 28, 1999
Expression of the proliferation and apoptosis-associated CAS protein in benign and malignant cutaneous melanocytic lesionsR Böni, A Wellmann, Y G Man, et al.
Cognitive Psychology|December 1, 1995
German inflection: the exception that proves the ruleG F Marcus, U Brinkmann, H Clahsen, et al.
Molecular Immunology|March 1, 1995
Preparation and characterization of a disulfide-stabilized Fv fragment of the anti-Tac antibody: comparison with its single-chain analogK O Webber, Y Reiter, U Brinkmann, et al.
Protein Engineering|December 1, 1995
Disulfide stabilization of antibody Fv: computer predictions and experimental evaluationY Reiter, U Brinkmann, S H Jung, et al.
Molecular and Cellular Biology|September 21, 2001
Cse1l is essential for early embryonic growth and developmentT K Bera, J Bera, U Brinkmann, et al.
Annals of the New York Academy of Sciences|June 30, 1995
Recombinant toxins: new therapeutic agents for cancerI H Pastan, L H Pai, U Brinkmann, et al.
Genomics|May 20, 1999
Tissue-specific alternative splicing of the CSE1L/CAS (cellular apoptosis susceptibility) geneU Brinkmann, E Brinkmann, T K Bera, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1992
Alteration of a protease-sensitive region of Pseudomonas exotoxin prolongs its survival in the circulation of miceU Brinkmann, L H Pai, D J FitzGerald, et al.
Anticancer Research|November 29, 2001
Implication of the proliferation and apoptosis associated CSE1L/CAS gene for breast cancer developmentP Behrens, U Brinkmann, F Fogt, et al.
Clinical Chemistry and Laboratory Medicine|November 30, 2000
How to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transportC Meisel, I Roots, I Cascorbi, et al.
The American Journal of Dermatopathology|April 28, 1999
Expression of the proliferation and apoptosis-associated CAS protein in benign and malignant cutaneous melanocytic lesionsR Böni, A Wellmann, Y G Man, et al.
Cognitive Psychology|December 1, 1995
German inflection: the exception that proves the ruleG F Marcus, U Brinkmann, H Clahsen, et al.
Molecular Immunology|March 1, 1995
Preparation and characterization of a disulfide-stabilized Fv fragment of the anti-Tac antibody: comparison with its single-chain analogK O Webber, Y Reiter, U Brinkmann, et al.
Protein Engineering|December 1, 1995
Disulfide stabilization of antibody Fv: computer predictions and experimental evaluationY Reiter, U Brinkmann, S H Jung, et al.
Molecular and Cellular Biology|September 21, 2001
Cse1l is essential for early embryonic growth and developmentT K Bera, J Bera, U Brinkmann, et al.
Annals of the New York Academy of Sciences|June 30, 1995
Recombinant toxins: new therapeutic agents for cancerI H Pastan, L H Pai, U Brinkmann, et al.
Genomics|May 20, 1999
Tissue-specific alternative splicing of the CSE1L/CAS (cellular apoptosis susceptibility) geneU Brinkmann, E Brinkmann, T K Bera, et al.
Pageof 10